{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T20:43:29Z","timestamp":1781037809003,"version":"3.54.1"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2005,1,25]],"date-time":"2005-01-25T00:00:00Z","timestamp":1106611200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Psychopharmacology"],"published-print":{"date-parts":[[2005,5]]},"DOI":"10.1007\/s00213-004-2093-2","type":"journal-article","created":{"date-parts":[[2005,1,24]],"date-time":"2005-01-24T12:37:57Z","timestamp":1106570277000},"page":"629-636","source":"Crossref","is-referenced-by-count":64,"title":["Short- and long-term efficacy and safety of risperidone in adults with disruptive behavior disorders"],"prefix":"10.1007","volume":"179","author":[{"given":"Carllo","family":"Gagiano","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen","family":"Read","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lilian","family":"Thorpe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mari\u00eblle","family":"Eerdekens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilse","family":"Van Hove","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2005,1,25]]},"reference":[{"issue":"Suppl 7","key":"CR1","first-page":"22","volume":"62","author":"DB Allison","year":"2001","unstructured":"Allison DB, Casey DE (2001) Antipsychotic-induced weight gain: a review of the literature. J Clin Psychiatry 62(Suppl 7):22\u201331","journal-title":"J Clin Psychiatry"},{"key":"CR2","first-page":"485","volume":"89","author":"MG Aman","year":"1985","unstructured":"Aman MG, Singh NN, Stewart AW, Field CJ (1985) The aberrant behavior checklist: a behavior rating scale for the assessment of treatment effects. Am J Ment Defic 89:485\u2013491","journal-title":"Am J Ment Defic"},{"key":"CR3","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1176\/appi.ajp.159.8.1337","volume":"159","author":"MG Aman","year":"2002","unstructured":"Aman MG, De Smedt G, Derivan A, Lyons B, Findling RL, and the Risperidone Disruptive Behavior Study Group (2002) Double-blind, placebo-controlled study of risperidone for the treatment of disruptive behaviors in children with subaverage intelligence. Am J Psychiatry 159:1337\u20131346","journal-title":"Am J Psychiatry"},{"key":"CR4","doi-asserted-by":"crossref","unstructured":"Brar JS, Ganguli, R, Pandina, G, Turkoz I, Berry S, Mahmoud R (in press) Effects of behavioral therapy on weight loss in overweight and obese patients with schizophrenia or schizoaffective disorder. J Clin Psychiatry","DOI":"10.4088\/JCP.v66n0208"},{"key":"CR5","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1089\/cap.2000.10.19","volume":"10","author":"JK Buitelaar","year":"2000","unstructured":"Buitelaar JK (2000) Open-label treatment with risperidone of 26 psychiatrically-hospitalized children and adolescents with mixed diagnosis and aggressive behavior. J Child Adolesc Psychopharmacol 10:19\u201326","journal-title":"J Child Adolesc Psychopharmacol"},{"key":"CR6","first-page":"233","volume":"7","author":"G Chouinard","year":"1980","unstructured":"Chouinard G, Ross-Canard A, Annable L, Jones BD (1980) The extrapyramidal symptom rating scale [abstract]. Can J Neurol Sci 7:233","journal-title":"Can J Neurol Sci"},{"key":"CR7","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1023\/A:1026069421988","volume":"28","author":"SA Cohen","year":"1998","unstructured":"Cohen SA, Ihrig K, Lott RS, Kerrick JM (1998) Risperidone for aggression and self-injurious behavior in adults with mental retardation. J Autism Dev Disord 28:229\u2013233","journal-title":"J Autism Dev Disord"},{"key":"CR8","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1056\/NEJMoa002028","volume":"346","author":"JG Csernansky","year":"2002","unstructured":"Csernansky JG, Mahmoud R, Brenner R (2002) A comparison of risperidone and haloperidol for the prevention of relapse in patients with schizophrenia. N Engl J Med 346:16\u201322","journal-title":"N Engl J Med"},{"key":"CR9","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1023\/A:1025926817928","volume":"29","author":"NA Dartnall","year":"1999","unstructured":"Dartnall NA, Holmes JP, Morgan SN, McDougle CJ (1999) Brief report: two-year control of behavioral symptoms with risperidone in two profoundly retarded adults with autism. J Autism Dev Disord 29:87\u201391","journal-title":"J Autism Dev Disord"},{"key":"CR10","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/S0891-4222(00)00061-5","volume":"22","author":"E Emerson","year":"2001","unstructured":"Emerson E, Kiernan C, Alborz A, Reeves D, Mason H, Swarbrick R, Mason L, Hatton C (2001) The prevalence of challenging behaviors: a total population study. Res Dev Disabil 22:77\u201393","journal-title":"Res Dev Disabil"},{"key":"CR11","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1080\/00332747.1988.11024387","volume":"51","author":"DP Farrington","year":"1988","unstructured":"Farrington DP, Gallagher B, Morley L, St Ledger RJ, West DJ (1988) Are there any successful men from criminogenic backgrounds? Psychiatry 51:116\u2013130","journal-title":"Psychiatry"},{"key":"CR12","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1111\/1469-7610.00414","volume":"39","author":"DM Fergussen","year":"1998","unstructured":"Fergussen DM, Horwood LJ (1998) Early conduct problems and later life opportunities. J Child Psychol Psychiatry 39:1097\u20131108","journal-title":"J Child Psychol Psychiatry"},{"key":"CR13","first-page":"155","volume":"33","author":"RL Findling","year":"1997","unstructured":"Findling RL, Maxwell K, Wiznitzer M (1997) An open clinical trial of risperidone monotherapy in young children with autistic disorder. Psychopharmacol Bull 33:155\u2013159","journal-title":"Psychopharmacol Bull"},{"key":"CR14","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1097\/00004583-200004000-00021","volume":"39","author":"RL Findling","year":"2000","unstructured":"Findling RL, McNamara NK, Branicky LA, Schluchter MD, Lemon E, Blumer JL (2000) A double-blind pilot study of risperidone in the treatment of conduct disorder. J Am Acad Child Adolesc Psych 39:509\u2013516","journal-title":"J Am Acad Child Adolesc Psych"},{"key":"CR15","first-page":"217","volume-title":"ECDEU assessment manual for psychopharmacology, revised 1976","author":"W Guy","year":"1976","unstructured":"Guy W (1976) Clinical global impressions. In: ECDEU assessment manual for psychopharmacology, revised 1976. National Institute of Mental Health, Rockville, MD, pp 217\u2013222"},{"key":"CR16","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1089\/cap.1995.5.273","volume":"5","author":"CJ McDougle","year":"1995","unstructured":"McDougle CJ, Brodkin ES, Yeung PP, Naylor ST, Cohen DJ, Price LH (1995) Risperidone in adults with autism or pervasive developmental disorder. J Child Adolesc Psychopharmacol 5:273\u2013282","journal-title":"J Child Adolesc Psychopharmacol"},{"key":"CR17","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1097\/00004583-199705000-00020","volume":"36","author":"CJ McDougle","year":"1997","unstructured":"McDougle CJ, Holmes JP, Bronson MR, Anderson GM, Volkmar FR, Price LH, Cohen DJ (1997) Risperidone treatment of children and adolescents with pervasive developmental disorders: a prospective, open-label study. J Am Acad Child Adolesc Psych 36:683\u2013693","journal-title":"J Am Acad Child Adolesc Psych"},{"key":"CR18","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1097\/00004583-199804000-00014","volume":"37","author":"R Nicolson","year":"1998","unstructured":"Nicolson R, Awad G, Sloman L (1998) An open trial of risperidone in young autistic children. J Am Acad Child Adolesc Psych 37:372\u2013376","journal-title":"J Am Acad Child Adolesc Psych"},{"key":"CR19","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1177\/070674379403900703","volume":"39","author":"SE Purdon","year":"1994","unstructured":"Purdon SE, Lit W, Labelle A, Jones BD (1994) Risperidone in the treatment of pervasive developmental disorder. Can J Psychiatry 39:400\u2013405","journal-title":"Can J Psychiatry"},{"key":"CR20","volume-title":"Deviant children grow up: a sociological and psychiatric study of sociopathic personality","author":"LN Robins","year":"1966","unstructured":"Robins LN (1966) Deviant children grow up: a sociological and psychiatric study of sociopathic personality. Williams & Wilkins, Baltimore, MD"},{"key":"CR21","first-page":"a","volume":"inventory","author":"Rojahn","year":"1992","unstructured":"Rojahn J (1992) Behavior problems inventory: a prospectus. Nisonger Center for Mental Retardation and Developmental Disabilities, Ohio State University","journal-title":"Behavior problems"},{"key":"CR22","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/S0140-6736(98)07059-7","volume":"354","author":"PJ Santosh","year":"1999","unstructured":"Santosh PJ, Baird G (1999) Psychopharmacotherapy in children and adults with intellectual disability. Lancet 354:233\u2013242","journal-title":"Lancet"},{"key":"CR23","first-page":"359","volume":"34","author":"EW Simon","year":"1996","unstructured":"Simon EW, Blubaugh KM, Pippidis M (1996) Substituting traditional antipsychotics with risperidone for individuals with mental retardation. Ment Retard 34:359\u2013366","journal-title":"Ment Retard"},{"key":"CR24","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1097\/00004583-200209000-00002","volume":"41","author":"R Snyder","year":"2002","unstructured":"Snyder R, Turgay A, Aman M, Binder C, Fisman S, Carroll A, and the Risperidone Conduct Study Group (2002) Effects of risperidone on conduct and disruptive behavior disorders in children with subaverage IQs. J Am Acad Child Adolesc Psych 41:1026\u20131036","journal-title":"J Am Acad Child Adolesc Psych"},{"issue":"Suppl 4","key":"CR25","first-page":"26","volume":"64","author":"AC Swann","year":"2003","unstructured":"Swann AC (2003) Neuroreceptor mechanisms of aggression and its treatment. J Clin Psychiatry 64(Suppl 4):26\u201335","journal-title":"J Clin Psychiatry"},{"key":"CR26","doi-asserted-by":"crossref","first-page":"e34","DOI":"10.1542\/peds.110.3.e34","volume":"110","author":"A Turgay","year":"2002","unstructured":"Turgay A, Binder C, Snyder R, Fisman S (2002) Long-term safety and efficacy of risperidone for the treatment of disruptive behavior disorders in children with subaverage IQs. Pediatrics 110:e34","journal-title":"Pediatrics"},{"key":"CR27","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1089\/104454601750143348","volume":"11","author":"M Bellinghen Van","year":"2001","unstructured":"Van Bellinghen M, De Troch C (2001) Risperidone in the treatment of behavioral disturbances in children and adolescents with borderline intellectual functioning: a double-blind, placebo-controlled pilot trial. J Child Adolesc Psychopharmacol 11:5\u201313","journal-title":"J Child Adolesc Psychopharmacol"},{"key":"CR28","first-page":"351","volume":"37","author":"PH Elteren Van","year":"1960","unstructured":"Van Elteren PH (1960) On the combination of independent two-sample tests of Wilcoxon. Bull Int Stat Inst 37:351\u2013361","journal-title":"Bull Int Stat Inst"},{"key":"CR29","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1111\/j.1600-0447.1993.tb03350.x","volume":"87","author":"R Borre Vanden","year":"1993","unstructured":"Vanden Borre R, Vermote R, Buttiens M, Thiry P, Dierick G, Geutjens J, Sieben G, Heylen S (1993). Risperidone as add-on therapy in behavioral disturbances in mental retardation: a double-blind placebo-controlled cross-over study. Acta Psychiatr Scand 87:167\u2013171","journal-title":"Acta Psychiatr Scand"},{"key":"CR30","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1097\/00004850-200207000-00001","volume":"17","author":"U Werneke","year":"2002","unstructured":"Werneke U, Taylor D, Sanders TAB (2002) Options for pharmacological management of obesity in patients treated with atypical antipsychotics. Int Clin Psychopharmacol 17:145\u2013160","journal-title":"Int Clin Psychopharmacol"},{"key":"CR31","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1352\/0895-8017(2001)106<0525:EOROAB>2.0.CO;2","volume":"106","author":"JR Zarcone","year":"2001","unstructured":"Zarcone JR, Hellings JA, Crandall K, Reese RM, Marquis J, Fleming K, Shores R, Williams D, Schroeder SR (2001) Effects of risperidone on aberrant behavior of persons with developmental disabilities: a double-blind crossover study using multiple measures. Am J Ment Retard 106:525\u2013538","journal-title":"Am J Ment Retard"}],"container-title":["Psychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00213-004-2093-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00213-004-2093-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00213-004-2093-2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,23]],"date-time":"2019-05-23T16:01:24Z","timestamp":1558627284000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00213-004-2093-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,1,25]]},"references-count":31,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2005,5]]}},"alternative-id":["2093"],"URL":"https:\/\/doi.org\/10.1007\/s00213-004-2093-2","relation":{},"ISSN":["0033-3158","1432-2072"],"issn-type":[{"value":"0033-3158","type":"print"},{"value":"1432-2072","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,1,25]]}}}